| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.74B | 51.94B | 54.78B | 53.31B | 51.06B | 46.89B |
| Gross Profit | 22.07B | 20.19B | 22.38B | 20.70B | 16.77B | 15.79B |
| EBITDA | 14.69B | 13.21B | 16.09B | 15.23B | 11.58B | 10.79B |
| Net Income | 7.75B | 7.11B | 7.83B | 7.01B | 4.94B | 4.49B |
Balance Sheet | ||||||
| Total Assets | 56.84B | 45.71B | 52.11B | 53.92B | 53.54B | 48.78B |
| Cash, Cash Equivalents and Short-Term Investments | 20.18B | 9.68B | 15.58B | 16.86B | 16.92B | 12.27B |
| Total Debt | 31.03B | 22.11B | 28.10B | 29.72B | 34.15B | 29.83B |
| Total Liabilities | 54.34B | 38.46B | 44.70B | 47.00B | 48.51B | 43.06B |
| Stockholders Equity | 2.50B | 7.25B | 7.41B | 6.92B | 5.03B | 5.72B |
Cash Flow | ||||||
| Free Cash Flow | 7.03B | 6.09B | 8.10B | 11.08B | 6.18B | 4.65B |
| Operating Cash Flow | 8.76B | 7.80B | 10.60B | 12.76B | 8.32B | 6.80B |
| Investing Cash Flow | -1.59B | -1.72B | -1.30B | -311.39M | -2.15B | -2.14B |
| Financing Cash Flow | 2.08B | -11.02B | -13.50B | -9.83B | -1.32B | -11.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $22.60B | 27.62 | 17.16% | 1.38% | 1.57% | 26.45% | |
69 Neutral | $124.85B | 12.84 | 26.01% | 3.74% | -13.78% | 11.80% | |
67 Neutral | $7.14B | 15.39 | 156.24% | 4.70% | 5.24% | 7.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $67.53B | -429.64 | 431.59% | 2.67% | 1.40% | -25.45% | |
60 Neutral | $32.61B | 15.36 | 155.28% | 5.03% | -14.08% | -19.70% | |
56 Neutral | $11.69B | 19.52 | 1502.49% | 5.05% | -5.68% | 66.74% |